Shanghai Haoyuan Chemexpress Co., Ltd. announced that it has received CNY 49.999962 million in funding from Shanghai Anxu Information Technology Co., Ltd., Shanghai Yuanmeng Enterprise Management Consulting Partnership (Limited Partnership), Ningbo Jiusheng Innovation Pharmaceutical Technology Co., Ltd, Shanghai Yuanli Enterprise Management Partnership

On December 28, 2022, Shanghai Haoyuan Chemexpress Co., Ltd. closed the transaction. The company issued 464,166 A shares for total gross proceeds of CNY 49,999,961.52. The company incurred total issuance expenses of CNY 9,483,018.87 and raised net proceeds of CNY 40,516,942.65 in the transaction.